var urlTotal,nextPageToken,postsDatePrefix=!1,accessOnly=!1,useApiV3=!1,apiKey="",blogId="",postsOrPages=["pages","posts"],jsonIndex=1,secondRequest=!0,feedPriority=0,amp="&"[0];function urlVal(){var e=window.location.pathname,t=e.length;return".html"===e.substring(t-5)?0:t>1?1:2}function urlMod(){var e=window.location.pathname;"p"===e.substring(1,2)?(e=(e=e.substring(e.indexOf("/",1)+1)).substr(0,e.indexOf(".html")),history.replaceState(null,null,"../"+e)):(e=(e=postsDatePrefix?e.substring(1):e.substring(e.indexOf("/",7)+1)).substr(0,e.indexOf(".html")),history.replaceState(null,null,"../../"+e))}function urlSearch(e,t){var n=e+".html";t.forEach(function(e){-1!==e.search(n)&&(window.location=e)})}function urlManager(){var e=urlVal();0===e?accessOnly||urlMod():1===e?getJSON(postsOrPages[feedPriority],1):2===e&&(accessOnly||history.replaceState(null,null,"/"))}function getJSON(e,t){var n=document.createElement("script");if(useApiV3){var o="https://www.googleapis.com/blogger/v3/blogs/"+blogId+"/"+e+"?key="+apiKey+"#maxResults=500#fields=nextPageToken%2Citems(url)#callback=bloggerJSON";nextPageToken&&(o+="#pageToken="+nextPageToken),nextPageToken=void 0}else o=window.location.protocol+"//"+window.location.hostname+"/feeds/"+e+"/default?start-index="+t+"#max-results=150#orderby=published#alt=json-in-script#callback=bloggerJSON";o=o.replace(/#/g,amp),n.type="text/javascript",n.src=o,document.getElementsByTagName("head")[0].appendChild(n)}function bloggerJSON(e){var t=[];if(useApiV3||void 0===urlTotal&&(urlTotal=parseInt(e.feed.openSearch$totalResults.$t)),useApiV3){try{e.items.forEach(function(e,n){t.push(e.url)})}catch(e){}nextPageToken=e.nextPageToken}else try{e.feed.entry.forEach(function(n,o){var r=e.feed.entry[o];r.link.forEach(function(e,n){"alternate"===r.link[n].rel&&t.push(r.link[n].href)})})}catch(e){}urlSearch(window.location.pathname,t),urlTotal>150?(jsonIndex+=150,urlTotal-=150,getJSON(postsOrPages[feedPriority],jsonIndex)):nextPageToken?getJSON(postsOrPages[feedPriority]):secondRequest&&(nextPageToken=void 0,urlTotal=void 0,jsonIndex=1,secondRequest=!1,0===feedPriority?(feedPriority=1,getJSON("posts",1)):1===feedPriority&&(feedPriority=0,getJSON("pages",1)))}function bloggerJS(e){e&&(feedPriority=e),urlManager()}bloggerJS(); //]]>

Wednesday, 14 August 2019

Cricket mai sabse Danger Batsman janiye click kare


Hello dosto aaj mai aapko batane wala ho sabse zyada runs banane wale cricketers in the history of cricket ye cricketers nay ODI test t20 pure format Mila kar runs banaye hai aur aaj hum in sab format k runs ko milakar yaha par list aapke samne rakhne wale hai.

1. Sachin Tendulkar
Our first in the list is Sachin Tendulkar inhone inke carrier k 664 matches 782 innings mai 34357 runs banaye hai with highest score of 248.

2. Kumar Sangakara
Kumar Sangakara Sri Lankan cricketer second number par hai. Inhone 594 matches 666 Iningns mai 28016 runs banaye with the highest score of 319.

3. Ricky Ponting
Ricky Ponting Australian cricketer one of the finest cricketer for Australia and world cricket. Inhone 560 matches 668 Iningns mai 27483 runs banaye with highest score of 257.

4. Mahela jayawardene
Mahela jayawardene again a Sri Lankan one the best batsman for Sri Lanka and world cricket. Mahela has played 652 matches 725 Iningns ans scored 25957 runs with the highest score of 374.

Thanks for reading please share as much as you can. 

Sunday, 11 August 2019

عید الاضحی کے لئے 21 لاکھ روپے کا بکرا جانئے پوری خبر

 : خوشامدید دوستو بکری عید کریب ہے ۔ اسیکے ک لئے
لوگ قربانی ک لئے بکرے فروخت کر رہے ہے ایسے ہی کانپور می ی ایک شکقص 21 لاکھ روپیہ میں بکرا بیچ رہا ہے انی نیوز سے بات کرتے وقت اسنے کہا ک یہ بکرا لاہوری نسل کا ہے اور اسکو روز کا 800 سے 900 روپیہ تک کا کرچ اتا ہے آپ اسکی فل ویڈیو نیچے دی گیی لنک پر کلک کرک دیکھ سکتے ہے

https://m.youtube.com/watch?v=JULwKOeztUg
سورس آ ن ی نیوز 

Saturday, 10 August 2019

Remote Possibilities: Where Mobility and Productivity Meet


(NewsUSA) - There is a revolution that has been taking place for quite some time in the business world, and it's changing the way workers use the telephone and companies do business.
Chances are you've heard of it. It's called Internet telephony, and experts agree that, among other things, it has made office PBX systems obsolete while increasing employee productivity by allowing a very mobile workforce to stay connected to their business lines, no matter where they're working from or which device they're using.
In short, this not-so-new technology is making the phone system digital in a way that takes advantage of the Internet and of any phone or computer attached to it.
To that end, Switch, a San Francisco-based communications company, is taking the cloud-based business phone concept to the next level by creating a system that can be integrated with Google Apps and, most recently (and notably), Microsoft Office 365.
"Work is a thing you do, not a place you go," said Craig Walker, CEO of Switch Communications. "We understand the value of mobility and giving people control over the tools they need to be productive, and Switch is designed with them in mind."
For Office 365 users, this latest development by Switch can accelerate employee productivity by integrating with Outlook mail, Outlook calendar and LinkedIn. Users can log in with their Microsoft credentials, have their Outlook contacts instantly synced, have their calendar and email integrated so they can see the most recent shared emails and appointments when on a Switch call, and have instant access to the always-current corporate directory.
Ease of administration is critical for a business of any size. Switch's design makes it easy to sign up in less than a minute using dropdown menus to let you set up a virtual receptionist for your company, set business hours to keep your cell phone from ringing at night or on holidays, record custom greetings, add department lines and more.
"Regardless of productivity suite, platform or size -- your business can be an enterprise or a three-person shop -- with Switch your phone system and your experience is and should be the same: easy-to-use, scalable and with the flexibility of a true cloud service."
The cost for companies of any size is a mere $15 per month per employee, including a free company number and unlimited domestic calls and texts.
"Switch makes sense for anyone who realizes their business phone system that serves a desk is broken," says Walker.
Visit www.switch.co or call 844-9-SWITCH to learn more.

Colonoscopies Get a Lot Easier Thanks to Technology


(NewsUSA) - Turning 50 seems to come with its own set of challenges, unlike any other age -- be it mental, emotional or physical. It's also when your doctor is likely to start urging you to get a colonoscopy even if you do not have any symptoms.
But what used to be an unpleasant, albeit necessary and routine procedure, has now become much less invasive, thanks to new technology. The "virtual colonoscopy" (or CT colonography) is now an option for most people who can't or don't want to get a standard colonoscopy. It's being embraced by many doctors and insurers nationwide.
Like its traditional counterpart, the virtual colonoscopy entails drinking a laxative 24 hours prior to the procedure. Unlike the traditional colonoscopy, which involves a long camera-tipped tube, the virtual exam inserts only about a two-inch soft tube that sends small puffs of gas to fill the colon so that a low-radiation dose computer-assisted CT or "CAT" scan can produce two- and three-dimensional views of the colon. The entire procedure takes about 15 to 20 minutes, so you don't need to be put to sleep and you can go right back to daily activities.
"It's very good in screening, and the patient's downtime is less," Dr. Guy Barat, a radiologist at Community Hospital in New Port Richey, Florida, told the St. Petersburg Times in an interview.
Some diehard traditionalists opine that you still would need a traditional colonoscopy to remove anything found by a virtual colonoscopy. However, the vast majority of exams don't find anything wrong, and the virtual test has been shown to dramatically increase screening rates. The virtual colonoscopy is an American Cancer Society-recommended screening exam. Even President Obama opted for a virtual colonoscopy over the standard test.
Experts say that the new technology can detect polyps the size of small blueberries, as well as cancer and other diseases. For the more than 140,000 Americans that are diagnosed with colorectal cancer every year, with nearly 50,000 dying largely due to late detection, this screening is vital.
The exam has been FDA approved since 1995, and major insurers, including Cigna, United Healthcare, Unicare, Blue Cross/Blue Shield and others, now cover their members for virtual colonoscopies to screen for colon cancer.
The American College of Radiology (ACR) says the last obstacle to tackle is to somehow get Medicare to cover beneficiaries for this life-saving exam so that seniors can have the same screening alternative as those with private insurance.
Currently, the U.S. Preventative Services Task Force is examining virtual colonoscopies. A "passing" grade from the USPSTF could lead directly to Medicare coverage under the Affordable Care Act.
For more information, please visit RadiologyInfo.org.

Turn to Telemedicine for Hassle-Free Health Care


(NewsUSA) - Sponsored News - Telemedicine -- the ability to access a physician or other health care provider remotely -- is becoming an integral part of health care, and an attractive option for many patients looking not only for medical expertise, but for convenience and cost savings as well.
Health insurers are increasingly offering telemedicine as an added benefit in medical plans as a way for members to connect remotely with medical providers, including doctors, psychologists and lactation consultants. These providers can be accessed easily via voice or video, on a mobile device, tablet, or laptop.
Telemedicine sessions with a medical expert are ideal for addressing non-emergency situations such as colds, allergies, headaches, nausea, sore throats, and skin conditions. Telemedicine allows patients to potentially avoid an unnecessary trip to the emergency room or urgent care center, and to speak with a doctor as soon as symptoms arise.
However, telemedicine should not be used for emergency situations; patients in these situations should call 911 or get to an emergency department immediately.
"While telemedicine is not meant to replace your doctor, it provides another avenue for people to receive care when and where they need it, whether they are in a rural community or a big city, and whether they are at home or on the go," says Beth Bierbower, president of Employer Group Segment for Humana, a leading health and well-being company.
For most telemedicine services, patients can use the phone or download a mobile app and create an account. Once a consultation is requested, the average wait time between requesting a session and speaking to a doctor is often less than 5 minutes.
Telemedicine services are offered through many health insurance plans. For example, Humana offers these services through the Doctor On Demand platform as a benefit on most of its group health plans nationwide. Check with your insurance carrier to see if telemedicine is a covered benefit on your health plan.
Telemedicine sessions often cost less for patients than in-person doctor visits, and offer a similar level of care to in-person medical services. Telemedicine clinicians are uniquely trained to treat patients virtually and are fully licensed to practice in a particular patient's state.
Many telemedicine platforms ask patients to complete a questionnaire before the session begins that gives the clinician relevant information, including health history and prescriptions, to streamline the patient experience. And, to ease any privacy-related fears, all sessions with a clinician are conducted using private, secure and confidential technology.
Visit humana.com/employertelemedicine to learn more about the benefits of telemedicine and how to use it as part of an overall health-care strategy.

Stem Cells, Biologics Could Be Answer to Next Generation Therapies


(NewsUSA) - Sponsored News - Biotech stocks tend to have their ups and downs among the investment community. However, the biotech industry is enjoying a shot in the arm with news of biologics flooding the wires.
Biologics, say experts, are different from traditional drugs because they are manufactured in a living system, such as a microorganism or plant or animal cells, rather than with synthesized chemicals. And because of the strides made in this biotechnology specialty, it is attracting the attention of the pharma big boys.
All the major players are looking to capture their share of a market that IMS Health analysts estimate will rise to $390 billion by 2020. In short, if the analysts are right, biologics will command nearly one-third of all spending on drugs in the next few years. Couple this with a marketing plan to the public that underscores biologics as natural derivatives instead of man-made, and it's easy to see why so much money is being poured into this area.
With patent expirations drawing near, and companies looking to get a leg up on their competition, big pharma will be looking to boutique firms in this space to get an edge on next-generation therapies.
Enter Endonovo Therapeutics (OTCQB: ENDV), a biotechnology company that is developing a bioelectronic approach to regenerative medicine through its premier platform, Cytotronics. While most biologics are formed using recombinant DNA technology, "Endonovo is falling back on its technology, which dates back to research at NASA seeking to develop stem cells and medical devices to treat potential injuries that astronauts might encounter during long term missions in outer space." In this way, the company is using Time-Varying Electromagnetic Field (TVEMF) technology to increase the therapeutic properties of stem cells. This, says the company, is accomplished through stimulation of magnetically induced electrical field pathways of cells and tissues.
Endonovo CEO Alan Collier describes the technology as "effectively training cells to secrete therapeutic proteins." The secreted proteins can include those commonly used in biologics, such as G-CSF (granulocyte-colony stimulating factor), GM-CSF (granulocyte-macrophage colony-stimulating factor), erythropoietin and interleukins that are used in angiogenesis, antigentargeting, promoting white blood cell growth to fight infections, and more.
Endonovo's mission is two-fold: to validate the potential of injecting "enhanced" or "trained" stem cells, but also to deliver a cocktail of therapeutic proteins that could exert their influence over inflammation while promoting tissue healing.
For more information on the company and its work, please visit www.endonovo.com.